Did we say that? AstraZeneca is now denying any intention of outsourcing all its manufacturing, saying the EVP who'd called production "not a core activity" was misquoted. But, the company says, it will begin looking to contract manufacturers in India and China for some active ingredients in various meds.
-read this article in Pharmafocus